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Introduction {#sec1}
============

Mechanistic modeling is the current gold standard for quantitative characterization and understanding of complex biological phenomena. However, mathematical analysis of rigorous mechanistic models is not yet the method of choice to address biological questions owing to a persistent gap in knowledge of the involved parameter values. Within this context, modeling without *a priori* values for the parameters is a radical claim. To see how radical, it helps to contrast the fundamentally new phenotype-centric approach implemented here with the conventional simulation-centric approach based on sampling and simulation ([@bib24], [@bib40]). Both approaches start with a typical qualitative hypothesis or model consisting of (1) the number of molecular elements, (2) their interactions with one another (connections), (3) the signs of their interactions (+/−), and (4) the stoichiometry of the interactions (number of molecules involved). Such a model would have numerous mechanistic parameters (rate constants, binding constants, equilibrium constants) whose values are unknown and difficult to determine.

In the conventional strategy, one samples parameter values, which can be done by randomly drawing values from a uniform distribution within a pre-defined range ([@bib19]), simulates the non-linear differential equations, and compares the results with the corresponding experimentally observed quantitative phenotypes of the system. This is repeated numerous times to select the values that tend to improve the fit between the simulated results and the experimental data (some examples of this methodology include the work by [@bib12], which implemented a coordinate search algorithm to find optimal parameter values; the work by [@bib41], which manually tuned parameter values; and the work by [@bib26], which used an evolutionary strategy to find a set of parameters that most closely matched experimental data). The result might be a good fit, one that is marginally acceptable, or no fit at all.

In contrast to this conventional approach, the phenotype-centric approach provides a fundamental advance that is entirely different. It starts with the same qualitative model as the conventional approach. However, well-stablished powerful linear analysis methods ([@bib35]) are used ([@bib29], [@bib30], [@bib31]) to identify and enumerate the entire repertoire of biochemical phenotypes for the model ([@bib33]). In this first step there is already the ability to discriminate among models/hypothesis; if the experimentally observed phenotype is not present in the repertoire, then the model can be eliminated ([@bib25]). On the other hand, if the phenotype of interest is present in the repertoire, then the same, powerful, well-stablished linear analytic methods can be used to predict a full set of parameter values that will realize that phenotype ([@bib10], [@bib24], [@bib40]).

Here, we introduce the Design Space Toolbox v.3.0 (DST3) to expand the capabilities of the Design Space formalism ([@bib33]). This new version builds on previous iterations of the software (DST1: [@bib10], implemented the general data structures; DST2: [@bib24], added parallelization routines and a graphical user interface) to allow the automatic identification and mathematical characterization of additional biochemical phenotypes arising from critically important under-determined cases.

These special phenotypes emerge from cycles, metabolic imbalances, and conservation constraints present in many biochemical systems. Examples of such systems include but are not limited to metabolic networks containing multiple reversible reactions ([@bib34]), a common motif leading to cycles; signaling cascades of chemical species with different regulatory states (e.g., achieved by different conformational or phosphorylation states) that are linked by conservation relationships ([@bib15], [@bib18]); and saturable processes, for which a pathway pool is imbalanced with respect its influx and efflux, thus generating a steady accumulation or depletion of material within the system ([@bib20], [@bib7]).

Besides the expanded computational engine of DST3, its C-library that is now able to handle these biologically important singularities automatically when they appear *individually and simultaneously*, the new version of the Design Space Toolbox (DST3) has further unique features that distinguish it from previous versions. First, the portability and installation of DST3 ([Figure S1](#mmc1){ref-type="supplementary-material"}) is greatly improved and simplified by using Docker ([@bib5]). Second, DST3 offers an improved and more stable IPython-based user interface for users with limited programming experience (refer to [Figures S2](#mmc1){ref-type="supplementary-material"} and [S5--S11](#mmc1){ref-type="supplementary-material"}). Third, calculating the product of the global tolerances ([@bib6]) for all parameters in log-coordinates, a proxy for a phenotype\'s volume in parameter space and for its associated global robustness ([@bib40]) is now automated within DST3. Fourth, solvers for systems of both ordinary differential (ODE) and differential algebraic (DAE) equations ([@bib27], [@bib3]) were incorporated, thus allowing a fully integrated dynamic characterization of the Full System. The analysis of the Full System by these completely different methodologies provides an independent means of confirming the results obtained by the Design Space methodology.

The Results section is divided into three sub-sections. The first sub-section reviews briefly key concepts of the Design Space formalism (see [@bib33] and [@bib10] for a more detailed theoretical treatment) needed to understand the advances described in this work. In the second sub-section, we build on these concepts to develop general mathematical strategies aimed at resolving matrix singularities arising from system topologies containing cycles, moiety conservations, and metabolic imbalances. In the third sub-section, we illustrate the capabilities of DST3 by analyzing a case study, the protocatechuate metabolic system of *Acinetobacter* ([@bib8], [@bib38]), a biochemical system exhibiting multiple, nested singularities. The [Methods](#sec6){ref-type="sec"} section provides details on the software architecture of DST3, the different ways to access its computational capabilities, and the installation instructions via Docker.

Results {#sec2}
=======

Review of Key Concepts {#sec2.1}
----------------------

Biochemical systems described by the power-law functions of chemical kinetics and the rational functions of biochemical kinetics can be represented by generalized mass action (GMA) kinetics ([@bib32]) of the form:$$\frac{dX_{i}}{dt} = \sum\limits_{k = 1}^{P_{i}}{\alpha_{ik}\prod\limits_{j = 1}^{n + m}X_{j}^{g_{ijk}} -}\sum\limits_{k = 1}^{Q_{i}}{\beta_{ik}\prod\limits_{j = 1}^{n + m}X_{j}^{h_{ijk}}}...i = 1,...,n_{c}$$$$0 = \sum\limits_{k = 1}^{P_{i}}{\alpha_{ik}\prod\limits_{j = 1}^{n + m}X_{j}^{g_{ijk}} -}\sum\limits_{k = 1}^{Q_{i}}{\beta_{ik}\prod\limits_{j = 1}^{n + m}X_{j}^{h_{ijk}}}\quad i = \left( {n_{c} + 1} \right),...,n$$where $\alpha_{ik}$ and $\beta_{ik}$ represent rate constants and $g_{ijk}$ $h_{ijk}$ are kinetic orders. $P_{i}$ and $Q_{i}$ are the number of positive and negative terms in the *i*-th equation, respectively. $X_{i}$ represent the variables of interest (typically the concentration of a biochemical species) in a system containing a total of $n$ dependent and $m$ independent variables. In general, dependent variables can be split into two groups: chemical variables, for which a differential equation exists, and auxiliary variables, for which algebraic constraints are defined. Each group contains $n_{c}$ and $n - n_{c}$ members, respectively. The set $n_{c}$ of chemical variables has a direct biological meaning and represents all the chemical/biological entities (i.e., enzymes, metabolites, chemical species, mRNA molecules) of a given system. On the other hand, the set $n - n_{c}$ of auxiliary variables has meaning in the context of recasting the system of ordinary differential equations into its GMA form. Independent variables for which a differential equation or algebraic constraint are not defined are treated as parameters.

For any system, one of the $P_{i}$ positive terms and one of the $Q_{i}$ negative terms in [Equation 1](#fd1){ref-type="disp-formula"} will momentarily dominate over the others in each one of the $n$ equations in the system. This gives rise to a so-called *dominant S-System* ([@bib29], [@bib33]), which can be generically described by [Equation 2](#fd2){ref-type="disp-formula"}:$$\frac{dX_{i}}{dt} = \alpha_{ip_{i}}\prod\limits_{j = 1}^{n + m}X_{j}^{g_{ijp_{i}}} - \beta_{iq_{i}}\prod\limits_{j = 1}^{n + m}X_{j}^{h_{ijq_{i}}}\quad i = 1,...,n_{c}$$$$0 = \alpha_{ip_{i}}\prod\limits_{j = 1}^{n + m}X_{j}^{g_{ijp_{i}}} - \beta_{iq_{i}}\prod\limits_{j = 1}^{n + m}X_{j}^{h_{ijq_{i}}}\quad i = \left( {n_{c} + 1} \right),...,n$$with $p_{i}$ and $q_{i}$ being the indices of the dominant positive and dominant negative term in the *i*-th equation, respectively. In steady state, [Equation 2](#fd2){ref-type="disp-formula"} can be combined into a single equation:$$0 = \alpha_{ip_{i}}\prod\limits_{j = 1}^{n + m}{X_{j}^{g_{ijp_{i}}} - \beta_{iq_{i}}\prod\limits_{j = 1}^{n + m}X_{j}^{h_{ijq_{i}}}}\quad i = 1,...,n$$

The validity of a dominant S-System in steady state implies certain conditions ([@bib33], [@bib10]), which are represented by inequalities of the form:$$\alpha_{ip_{i}}\prod\limits_{j = 1}^{n + m}X_{j}^{g_{ijp_{i}}} > \alpha_{ik}\prod\limits_{j = 1}^{n + m}X_{j}^{g_{ijk}}\quad\forall k = \left\{ 1,2,3,...,P_{i} \middle| k \neq p_{i} \right\}$$$$\beta_{iq_{i}}\prod\limits_{j = 1}^{n + m}X_{j}^{h_{ijq_{i}}} > \beta_{ik}\prod\limits_{j = 1}^{n + m}X_{j}^{h_{ijk}}\quad\forall k = \left\{ 1,2,3,...,Q_{i} \middle| k \neq q_{i} \right\}\text{.}$$

Here, $k$ represents indices of corresponding non-dominant terms. Steady-state concentrations of the dependent variables can be obtained in three steps ([@bib29], [@bib10]). By rearranging [Equation 3](#fd3){ref-type="disp-formula"} and taking logarithms, one obtains [Equation 6](#fd6){ref-type="disp-formula"}:$$\log\ \alpha_{ip_{i}} + \sum\limits_{j = 1}^{n + m}{g_{ijp_{i}}\ \log\ X_{j} =}\log\ \beta_{iq_{i}} + \sum\limits_{j = 1}^{n + m}{h_{ijq_{i}}\ \log\ X_{j}}\text{,}$$which can be written in matrix form as:$$Ay = b\text{,}$$where $y_{j} = \ln\ X_{j}$, $a_{ij} = g_{ijp_{i}} - h_{ijq_{i}}$, and $b_{i} = \ln\left( \beta_{in}/\alpha_{iq} \right)$. In a second step, dependent ($y_{D}$) and independent ($y_{I}$) variables are split to obtain:$$A_{D}y_{D} = b - A_{I}y_{I}\text{.}$$

The vector of dependent concentration variables $y_{D}$ can be obtained in a third step by matrix operations:$$y_{D} = A_{D}^{- 1}b - A_{D}^{- 1}A_{I}y_{I}.$$

The vector of dependent flux variables $\log\ F_{i}$ is obtained by matrix multiplication:$$\log\ F = Gy.$$

The concept of biochemical phenotype (or simply *phenotype*) is an integral element of the Design Space formalism and will be broadly used throughout this work. A phenotype is defined in the context of a mechanistic mathematical model of a given biological system. The mathematical representation of a biochemical system decomposed into its repertoire of steady-state phenotypes, each given by a set of dominant S-system equations ([Equation 3](#fd3){ref-type="disp-formula"}) and associated boundaries, involves a comprehensive integration of information for all the system\'s concentrations, fluxes, and parameters ([@bib33], [@bib10]). From a biological point of view, most of the mathematical properties of a biochemical phenotype, for instance, its dynamic behavior (discussed in section "[Phenotype Analysis Reveals Dynamic Properties of the System](#sec2.3.2){ref-type="sec"}") and logarithmic gains (discussed in section "[Logarithmic Gains Can Guide the Design of Engineering Strategies](#sec2.3.3){ref-type="sec"}") can be experimentally observed and measured, thus rendering biochemical phenotypes a powerful tool for the elucidation of design principles for natural systems and for the design of synthetic networks with novel functionalities.

Strategies for Treating Three Types of Singularities {#sec2.2}
----------------------------------------------------

Earlier versions of the Design Space Toolbox ([@bib10], [@bib25]) have exclusively dealt with cases for which the inverse of the matrix $A_{D}$ exists ([Figure S4](#mmc1){ref-type="supplementary-material"}). However, a number of important system topologies---cycles, conservations, metabolic imbalances ([Figure 1](#fig1){ref-type="fig"})---cause the matrix $A_{D}$ to become singular and effectively limit the utility of earlier versions of the Design Space Toolbox. The ubiquity of such topologies in biochemical networks renders their automatic handling highly relevant in the context of the Design Space formalism.Figure 1Systems Containing Cycles, Conservation Constraints, and Metabolic Imbalances(A) A cycle comprising three metabolic species is shown. Mass action kinetics is used to mathematically describe the flux through each reaction. Rate constants for each one of these reactions are shown.(B) If the fluxes represented by the blue arrows dominate over the others, a singularity arises that prevents the system from having a unique steady-state solution. This singularity is resolved by introducing a mass balance equation around a control volume (blue rectangle) containing the cycle.(C) Three-component system containing one conservation constraint. Fluxes to and from metabolite pools $X_{1}$, $X_{2}$, and $X_{3}$ are mathematically described using mass action kinetics.(D) No fluxes enter or leave the control volume (blue rectangle) around metabolites involved in the conservation.(E) Metabolic pool with one input and one output flux. Depending on the numerical values of fluxes $v_{0}$ and $v_{1}$, the concentration of $X_{1}$ can steadily increase ($v_{0} > v_{1}$), decrease ($v_{0} < v_{1}$), or remain unchanged over time ($v_{0} = v_{1}$).

The mathematical framework presented here to deal with these singularities can be seen as an extension of previous theory with *ad hoc* applications in a more limited context by our group (refer to [@bib29] for metabolic imbalances; [@bib2] for conservations; [@bib36] for cycles). The extension presented in this work generalizes the theory and automates the computational applications thereby expanding the Design Space formalism ([@bib33]). The strategies are illustrated by means of simple examples treated briefly below with mathematical details given in section "[Strategies for Treating Three Types of Singularities](#sec2.2){ref-type="sec"}" of the [Supplemental Information](#appsec1){ref-type="fn"}.

### Cycles Are Resolved by Considering Global Dominance Equations {#sec2.2.1}

Cycles of reactions are a common feature of biochemical systems. They typically have a number of input and output fluxes. A simple example is the fumarate nitrate reduction (FNR) regulator of *Escherichia coli* that exists in a cycle with three forms having one influx and two effluxes ([@bib36]). The FNR global regulator is responsible for sensing the environment, more specifically the availability of O~2~. It modifies the global gene expression of the cell to adapt its machinery for the transition from aerobic to anaerobic growth. Let us consider the simple system shown in [Figure 1](#fig1){ref-type="fig"}A, in which species $X_{1}$, $X_{2}$, and $X_{3}$ interact to form a substrate cycle driven far from thermodynamic equilibrium. This example is deliberately selected to focus on the mathematical details of the singularity contained in the kinetic equations and on the strategy that resolves it. We start by setting up equations to describe the change in the concentration of each chemical species over time. Mass action kinetics are used to generate the rate laws describing the flux through each reaction. The resulting expressions are then combined by means of Kirchhoff\'s node law to generate balance equations for each metabolite in the system.

The Design Space formalism ([@bib33]) can be applied to decompose this set of equations into different cases, each having a unique set of dominant terms and being valid within a specific region in parameter space. One such case for this system is case number 27, with case signature \[22 11 21\]. This signature contains three pairs of indices, one for each equation, indicating the identity of the positive and negative term dominating in each equation. Visual inspection of the matrix $A_{D}$ for this case reveals the presence of a linear dependency among its rows, and, thus, there is no unique steady-state solution. Nevertheless, the system of algebraic equations is consistent and a solution (or set of solutions) can be found by analyzing global dominance conditions on the influxes and effluxes that describe a mass balance around the cycle present in this system.

Once the extended system has been automatically set up, the Design Space formalism can be applied to identify valid sub-cases that resolve the cyclical case. [Table S1](#mmc1){ref-type="supplementary-material"} shows S-system equations for each one of the six valid sub-cases generated from the extended system. Note the special form of these equations. S-systems originating from the dominance analysis of the global dominance equation are used to replace the differential equation for the pool with the dominant efflux. For instance, the expression $\alpha_{11} - \beta_{11}X_{1}$ (obtained when the first positive and first negative term in the global dominance equation are dominant) is used to replace the differential equation for $X_{1}$ (refer to sub-case 1 in [Table S1](#mmc1){ref-type="supplementary-material"}). Additionally, this expression is scaled to match the coefficient of the negative term in the Full System (i.e., the original set of equations). Consider for instance the expression $\alpha_{11} - 2\beta_{33}X_{3}$, which is obtained when the first positive and third negative term in the global dominance equation are dominant. Since the coefficient of the negative term in the original equation is 1, the scaled expression $\frac{1}{2}\alpha_{11} - \beta_{33}X_{3}$ is used to construct sub-case 3 of [Table S1](#mmc1){ref-type="supplementary-material"}.

Owing to the special way in which terms stemming from the global dominance equation are used to construct equations for sub-cases, a three-digit case signature is introduced. This allows for tracking the origin of terms that make up the S-systems of these sub-cases. In addition to the indices of dominant positive and negative terms contained in the traditional two-digit signature, the extended three-digit signature contains the index of the equation from which its positive dominant term originated. Consider, for instance, the case signature for sub-case 27_5 in [Table S1](#mmc1){ref-type="supplementary-material"} and its associated S-system. The signature \[22 **3**12 21\] dictates that differential equations for pools $X_{1}$ and $X_{3}$ are constructed by picking dominant terms in the traditional way, whereas the differential equation for pool $X_{2}$ is made from the first positive term of the *third* equation and the second negative term of the *second* equation.

### Conserved Moieties Are Handled by Considering the Total Size of Conserved Pools {#sec2.2.2}

Pools of metabolites with constant total concentration, on some timescale, are a common feature of complex metabolic and signaling systems. They involve conserved moieties, which are groups of atoms that remain intact in all reactions of a system. AMP, NAD^+^, and NADP^+^ are prominent examples of conserved moieties in energy metabolism ([@bib15]). Consider the simple system in [Figure 1](#fig1){ref-type="fig"}C with three components linked by a conservation relationship. As in the case of the cycles in section "[Cycles Are Resolved by Considering Global Dominance Equations](#sec2.2.1){ref-type="sec"}," the presence of conservations causes the matrix $A_{D}$ to be singular, since the three concentrations are not independent. Nevertheless, steady-state solutions can be obtained by discarding one of the differential equations and adding the algebraic constraint that the sum of the three concentrations must equal their conserved amount.

The analysis of the differential-algebraic system using the Design Space formalism involves the usual generation of cases by picking dominant terms for each of the equations of the system. The three cases that result are shown in [Table S2](#mmc1){ref-type="supplementary-material"}. Note that each case is defined by only two differential equations and one algebraic constraint. In order to capture the special way in which the equations are constructed for each case, the indices of the differential equation being deleted are set to zero in the case signature. Case 3, for instance, in which the differential equation for pool $X_{3}$ is missing, has a case signature of \[11 11 **00** 13\] to reflect this fact.

### Metabolic Imbalances Are Treated by Considering Knife-Edge Conditions {#sec2.2.3}

Flux imbalances are frequently encountered in the metabolism of engineered microbial strains ([@bib7], [@bib13], [@bib1]) and in inborn metabolic diseases such as phenylketonuria ([@bib20]) and maple syrup urine disease ([@bib16]), often by the excretion of some metabolite. Let us consider the simplest example of a metabolic pool as shown in [Figure 1](#fig1){ref-type="fig"}E with one input ($v_{0}$) and one output ($v_{1}$) flux, where $v_{0}$ is a constant and the output flux is described by a Michaelis-Menten rate law $v_{1} = \left( {V_{M}X_{1}K_{M}^{- 1}} \right)\left( {1 + X_{1}K_{M}^{- 1}} \right)^{- 1}$. $K_{M}$ and $V_{M}$ represent the Michaelis constant and maximal reaction rate, respectively. The change in concentration of metabolite $X_{1}$ over time can be described by the generalized mass action system$$\frac{dX_{1}}{dt} = v_{0} - V_{M}K_{M}^{- 1}X_{1}D^{- 1}$$$$0 = 1 + K_{M}^{- 1}X_{1} - D\text{.}$$where $D$ represents an auxiliary variable introduced in the recasting process to describe the denominator of the Michaelis-Menten rate law. Let us now consider the equations for the case with signature \[11 21\]:$$\frac{dX_{1}}{dt} = v_{0} - V_{M}K_{M}^{- 1}X_{1}D^{- 1}$$$$0 = K_{M}^{- 1}X_{1} - D\text{,}$$which together with its associated dominance condition$$K_{M}^{- 1}X_{1} > 1,$$imply$$\frac{dX_{1}}{dt} = v_{0} - V_{M}\text{.}$$

This system does not have a steady-state solution. Indeed, [Equation 16](#fd16){ref-type="disp-formula"} only provides a consistency condition for the concentration of $X_{1}$ to remain unchanged over time: $0 = v_{0} - V_{M}$. We will refer to this kind of constraint as a *knife-edge condition*. In general, we are interested in the behavior of the system when knife-edge conditions are not satisfied, i.e., $v_{0} \neq V_{M}$. Violating the knife-edge condition in a specific direction implies an extreme value for $X_{1}$:$\left. X_{1}\rightarrow\infty \right.$ or $\left. X_{1}\rightarrow 0 \right.$. The validity of either situation is assessed by checking the validity of the associated dominance conditions, as shown in [Table S3](#mmc1){ref-type="supplementary-material"}. Taken together, these results indicate that, for the system shown in [Figure 1](#fig1){ref-type="fig"}E, the concentration of the pool $X_{1}$ will steadily increase over time, i.e., it will *blow up* if the system\'s parameters fulfill the conditions $K_{M}^{- 1}X_{1} > 1$ and $v_{0}V_{M}^{- 1} > 1$.

Note that the case with signature \[11 11\], and associated dominance condition, has a conventional steady-state solution given by $X_{1} = v_{0}K_{M}V_{M}^{- 1}$ for $K_{M}^{- 1}X_{1} < 1$. The general procedure for treating cases with multiple knife-edge conditions is presented in section "[Metabolic Imbalances are Treated by Considering Knife-Edge Conditions](#sec2.2.1){ref-type="sec"}" of the [Supplemental Information](#appsec1){ref-type="fn"}.

Analysis of a Biochemical System Exhibiting Multiple Singularities {#sec2.3}
------------------------------------------------------------------

For a case study, we have selected the protocatechuate degradation pathway of *Acinetobacter* sp. strain ADP1. Protocatechuate is a chemical compound derived from phenolic species including p-cresol, 4-hydroxybenzoate, and numerous lignin monomers and is converted to β-ketoadipate by the pathway under study ([@bib14]). The protocatechuate degradation pathway is one of the two branches of the β-ketoadipate pathway and is widely distributed among taxonomically diverse eubacteria and fungi ([@bib14]). The ecological importance of the β-ketoadipate pathway resides in its key role in recycling vast amounts of aromatic material in the natural carbon cycle. From an industrial point of view, the protocatechuate degradation pathway plays a central role in the valorization of lignin for the production of fuels, chemicals, and materials ([@bib21], [@bib28]) as well as in the detoxification of environmental pollutants ([@bib14]). There are many microbes capable of these industrially important processes in the context of toxic environmental hydrocarbons. Although they may have similar if not identical pathways for these functions, their genomic architectures exhibit major differences that are not well understood ([@bib17], [@bib14]). One of the simplest of these architectures for the transport and catabolism of protocatechuate is found in *Acinetobacter* sp. strain ADP1. Its genetic system encodes a single polycistronic mRNA for transporter and catabolic enzymes of the protocatechuate specific pathway, as well as several shared enzymes ([@bib38], [@bib8]). For our purposes, we shall focus only on the protocatechuate specific pathway illustrated in [Figure 2](#fig2){ref-type="fig"}A (refer to [Table S5](#mmc1){ref-type="supplementary-material"} in the [Supplemental Information](#appsec1){ref-type="fn"} for a summary of symbols used in this section). The system is composed of a signaling cascade, a gene circuit, and a metabolic module. The transcription factor (PcaU) functions as both a repressor ($U_{1}$) and an activator ($U_{2}$) and has a conserved total concentration of $U_{T} = U_{1} + U_{2}$. It controls the synthesis of a polycistronic mRNA ($M_{3}$) that encodes the transporter, PcaK ($T_{4}$), and several enzymes, three of which constitute this pathway: protocatechuate 3,4-dioxygenase, PcaGH ($GH_{5}$), $\beta$-carboxy-*cis*,*cis*-muconate cycloisomerase, PcaB ($B_{6}$), and 4-carboxymuconolactone decarboxylase, PcaC ($C_{7}$). The environmentally supplied substrate protocatechuate ($P_{0}$) is transported into the cell where it becomes intracellular protocatechuate ($P_{8}$), which is both a metabolic intermediate and the natural inducer for the transcription factor. The following metabolites in the pathway are β-carboxy-*cis*,*cis*-muconate ($CM_{9}$) and γ-carboxymuconolactone ($CL_{10}$) ([@bib8]).Figure 2Integrated System Exhibiting Multiple Singularities and its Characterization by DST3(A) The signaling module responds to the inducer signal $P_{8}$, which stimulates the conversion of the transcription factor from the repressor $U_{1}$ into the activator $U_{2}$ form. The regulator controls the synthesis of a polycistronic mRNA molecule $M_{3}$, from which four proteins $T_{4}$, $GH_{5}$, $B_{6}$, and $C_{7}$ are translated. Transporter $T_{4}$ catalyzes the import of metabolite $P_{8}$ into the cell from an external pool $P_{0}$. Enzymes $GH_{5}$ and $B_{6}$ then catalyze the reversible conversion of $P_{8}$ into $CM_{9}$ and $CM_{9}$ into $CL_{10}$. The last enzyme $C_{7}$ catalyzes the conversion of $CL_{10}$ into the end-product β-ketoadipate enol-lactone (not shown).(B) A **Design Space Plot** around phenotype **7633** is shown. The white dot represents the operating point of the system, which is automatically calculated using the **Analyze Case** tab of the DST3 user interface. Parameter values predicted for this operating point are: $\text{K}_{1} = 0.316227766017$, $\text{K}_{2} = 0.1$, $\text{K}_{\text{M}0} = 10.0$, $\text{K}_{\text{M}5\text{f}} = 1.0$, $\text{K}_{\text{M}5\text{r}} = 1.0$, $\text{K}_{\text{M}6\text{f}} = 1.0$, $\text{K}_{\text{M}6\text{r}} = 1.0$, $\text{K}_{\text{M}7} = 1.0$, $\text{K}_{\text{eq}5} = 10.0$, $\text{K}_{\text{eq}6} = 1.0$, $\text{U}_{\text{T}} = 1.0$, $\text{P}_{0} = 1.0$, $\alpha_{1} = 1.0$, $\alpha_{3\text{basal}} = 0.1$, $\alpha_{3\max} = 1.0$, $\alpha_{3\min} = 0.01$, $\alpha_{4} = 1.0$, $\alpha_{5} = 1.0$, $\alpha_{6} = 1.0$, $\alpha_{7} = 10.0$, $\text{β}_{1} = 1.0$, $\text{β}_{3} = 1.0$, $\text{β}_{4} = 1.0$, $\text{β}_{5} = 1.0$, $\text{β}_{6} = 1.0$, $\text{β}_{7} = 1.0$, $\text{k}_{\text{cat}4} = 1.0$, $\text{k}_{\text{cat}5} = 1.0$, $\text{k}_{\text{cat}6} = 1.0$, $\text{k}_{\text{cat}7} = 1.0$; Kinetic order(s): $\text{m} = 2$, $\text{p} = 2$; Parametric constraints: $\alpha_{3\max} > \alpha_{3\text{basal}} > \alpha_{3\min}$.(C) A **Trajectories Plot** is used to characterize the operating point shown in (B) The solid gray line represents the evolution of the system starting from an initial state in which all concentrations are set to 0.001. The gray star represents the steady state reached by the system after numerical integration for 500 time units. Refer to [Table S7](#mmc1){ref-type="supplementary-material"} for further details on the numerical solvers used by DST3. The black dot next to the gray star represents the steady state predicted by DST3 for phenotype **7633** using linear algebra.(D) The operating point of the system has been modified by decreasing $\text{k}_{\text{cat}5}$ from 1.0 to 0.01 so that it is now contained within the region of the pathological phenotype **7718.1**.(E) A **Trajectories Plot** is used to characterize the operating point shown in (D) The temporal behavior of metabolite pools $P_{8}$ and $CM_{9}$ is shown. $CM_{9}$ reaches a steady state of approximately 0.01, whereas the concentration of $P_{8}$ continuously increases over time and does not reach a steady state. The gray star represents the state of the system after numerical integration for 50,000 time units. When integrated for a longer period of time, the gray star continues moving further to the right at a constant $\text{CM}_{9}$ concentration, till it eventually reaches and passes the location of the black dot. Initial conditions are the same as in (C).

This system exhibits all three types of singularities discussed in section "[Strategies for Treating Three Types of Singularities](#sec2.2){ref-type="sec"}," thus making it an excellent example for demonstrating the relevance of our work. It contains a conservation relationship from the transcription factor, cycles from the reversible enzymatic reactions within the metabolic pathway, and blow-ups from imbalances within the same pathway. The dynamics of the system can be described by a set of differential algebraic equations involving 30 parameter values, which can be considered unknown for our purposes here. Refer to [Equations S34--S45](#mmc1){ref-type="supplementary-material"} in the [Supplemental Information](#appsec1){ref-type="fn"} for details on the mathematical model and to [Tables S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"} for an overview of the symbols used and their biological context.

### Filtering the Phenotypic Repertoire for Phenotypes of Interest {#sec2.3.1}

Enumerating the phenotypic repertoire of a system is typically the first step in the phenotype-centric modeling strategy ([@bib40]). Even systems of moderate size can exhibit a surprisingly large number of biochemical phenotypes. Therefore, the second important step is to filter the repertoire for the phenotypes of interest. For example, filtering for cases with 2 eigenvalues with positive real part can be used to identify oscillatory phenotypes ([@bib22]), filtering for cases with 1 eigenvalue with positive real part can be used to identify multi-stability and hysteresis ([@bib11]), and filtering for a logical function consisting of a pattern of dependent variables that increase, decrease, or remain unchanged in response to a change in an independent variable can be used for model discrimination ([@bib24]). Since all of the phenotype characteristics can be exported from DST3 to an Excel spread sheet, many types of user-defined filters can be customized to meet the user\'s needs (see part 3 of the tutorial contained within the DST3 Docker image for an example).

Here, we show how one can progressively filter the repertoire of the protocatechuate system to narrow the focus on phenotypes of interest. If we allow for all possibilities, DST3 shows that the system represented in [Figure 2](#fig2){ref-type="fig"}A is capable of exhibiting 3,450 valid phenotypes, of a total of 10,368 potential phenotypes ([Figure S7](#mmc1){ref-type="supplementary-material"}). However, we can progressively filter this list automatically to include only those phenotypes of interest. In the context of this case study, we are interested in the steady states of this system that maximizes the pathway flux, while minimizing the accumulation of toxic intermediates. First, if we filter for phenotypes that are non-pathological by not checking for blow-ups ([Figure S5](#mmc1){ref-type="supplementary-material"}), i.e., that do not have imbalances resulting in concentrations that continuously increase or decrease, then the number of non-pathological phenotypes is 384 and they are all stable (all eigenvalues have a negative real part). Second, if we filter these for phenotypes that respond to changes in the environmental substrate $P_{0}$, by requiring a non-zero logarithmic gain in metabolite concentrations and pathway flux in response to a change in substrate, then there are only 192 responders. Third, if we filter these for phenotypes that are inducible, by requiring a non-zero logarithmic gain in mRNA in response to changes in substrate, then there are only 64 inducible responders. Finally, if we group the inducible phenotypes for specific non-zero logarithmic gains in mRNA, then we find only three values: $\text{L}\left( {\text{M}_{3},\text{P}_{0}} \right) = 2$ with 32 examples, $\text{L}\left( {\text{M}_{3},\text{P}_{0}} \right) = 4$ with 28 examples, and $\text{L}\left( {\text{M}_{3},\text{P}_{0}} \right) = 6$ with 4 examples.

Following this initial screening, the DST3 can be used to characterize automatically the inducible responders by comparing them on the basis of three functional criteria: global robustness to a change in phenotype, energy index (maximum flux with minimum production of protein machinery), and toxicity index (maximum flux with minimum accumulation of toxic intermediates). Global robustness is determined by the product of the global tolerances ([@bib6]) for all of the parameters of the system, which is a proxy for the volume of the phenotype\'s polytope in the system Design Space---note that the ability to automatically compute phenotypic volumes is exclusive to DST3. We define the energy index as the cost/benefit determined by the ratio of the logarithmic gain in mRNA, which is a proxy for the increased expenditure of energy for protein production, to the logarithmic gain in the pathway flux produced, $energy\mspace{9mu} index = L\left( M_{3},P_{0} \right)/L\left( F,P_{0} \right)$. The toxicity index is the cost/benefit determined by the ratio of the logarithmic gain in the toxic intermediate, protocatechuate ($P_{8}$), to the logarithmic gain in the pathway flux produced, $toxicity\mspace{9mu} index = L\left( P_{8},P_{0} \right)/L\left( F,P_{0} \right)$.

The results summarized in [Table 1](#tbl1){ref-type="table"} show that 32 of the 64 phenotypes have the best global robustness, best energy index, and best toxicity index. The next 28 phenotypes have intermediate values for these three criteria and the remaining 4 phenotypes have the worst global robustness and worst energy and toxicity indices. There is a clear trade-off revealed by this analysis. The pathway flux can be increased by moving from the phenotypes in the first group to those in the third group, but only by sacrificing global robustness, energy efficiency, and toxicity. Note that generation of the results in [Table 1](#tbl1){ref-type="table"} did not require any kind of simulation or optimization. Rather, it involved the application of linear algebra to analyze phenotype-specific properties, such as logarithmic gains and phenotypic volumes, that were used to compare a given set of biochemical phenotypes using three different criteria: global robustness as well as energy and toxicity indices. After values for these criteria were calculated, the set of phenotypes were distributed into three different groups. Then, these groups were sorted by its total normalized volume (global robustness).Table 1Repertoire of 64 Biochemical Phenotypes of the Protocatechuate Pathway that Are Responding to Substrate, Are Stable and InducibleGroup123Number of phenotypes in group32284Representative phenotype763376587593$\text{L}\left( {\text{M}_{3},\text{P}_{0}} \right)$246$\text{L}\left( {\text{P}_{8},\text{P}_{0}} \right)$123$\text{L}\left( {\text{CM}_{9},\text{P}_{0}} \right)$112$\text{L}\left( {\text{CL}_{10},\text{P}_{0}} \right)$111$\text{L}\left( {\text{F},\text{P}_{0}} \right)$357Normalized volume of representative phenotype1.94 × 10^−8^9.46 × 10^−12^9.72 × 10^−16^Total normalized volume of group5.61 × 10^−7^5.32 × 10^−11^3.40 × 10^−15^Energy index0.670.800.86Toxicity index0.330.400.43[^2]

### Phenotype Analysis Reveals Dynamic Properties of the System {#sec2.3.2}

Let us consider the phenotype numbered **7633** as a representative member of the best class, which could conceivably have been selected in nature. We start our analysis by using DST3 to predict specific values for each one of the 30 parameters required to fully define an operating point of the system within phenotype **7633** along with its phenotypic boundaries. For that, we use the **Analyze Case** tab ([Figure S9](#mmc1){ref-type="supplementary-material"}A) within the **Main Menu** of the DST3 user interface. Note that an analogous analysis can be performed for any other phenotype.

Since we have the ability to characterize the Full System exhibiting this phenotype, we can ask if there might be a strategy for further improving its performance (section "[Logarithmic Gains Can Guide the Design of Engineering Strategies](#sec2.3.3){ref-type="sec"}") or for avoiding dysfunction through rational engineering. An obvious dysfunction occurs when there is a violation of one of the most basic design principles, namely, the maximal velocity of a downstream enzyme should be greater than that of the upstream enzymes in the pathway ([@bib33]). The relation of this pathology to the phenotype **7633** is made evident in a **Design Space Plot** ([Figure 2](#fig2){ref-type="fig"}B) with the turnover number ($k_{cat5}$) for the enzyme converting intracellular protocatechuate ($P_{8}$) to β-carboxy-cis,cis-muconate ($CM_{9}$) on the y axis. The relative location of physiologically relevant phenotypes coded by color is shown in [Figure 2](#fig2){ref-type="fig"}B. The operating point of the system, which was automatically calculated by DST3, is represented by the white dot within the valid region for phenotype **7633** (red polytope). In this specific view of the Design Space, the white blank region in the lower portion of the plot indicates the location of pathological phenotypes exhibiting metabolic imbalances.

The dynamical behavior of the Full System, when its steady-state operating point is located within the valid region for phenotype **7633,** can be studied by simulation using a **Trajectories Plot** ([Figure 2](#fig2){ref-type="fig"}C), one of three types of plots available in the **Full System** tab of the **Main Menu**. This plot shows the evolution of the system starting from a set of initial conditions to reach its steady state, which is marked by a gray star in [Figure 2](#fig2){ref-type="fig"}C. The black dot in this figure represents the steady-state prediction made by DST3 for phenotype **7633** using linear algebra. The relative position of the black dot and the gray star in the trajectories plot demonstrates the accuracy of DST3 when approximating steady states. The **Full System** tab also allows *dynamic* phenotypes (case number and signature) to be reported at each point in the solution when there is a change in dominance conditions; this is currently implemented as an exportable.xlsx file (data not shown). In the specific example of the trajectory shown in [Figure 2](#fig2){ref-type="fig"}C, the initial conditions of the system locate its operating point in phenotype 1515. As the concentrations of the pools in the system evolve toward a steady state, the operating point of the system transits through phenotypes 649 and 721 to finally reach its steady state located within phenotype **7633**.

DST3 makes it possible to identify the nature of pathological phenotypes. By clicking the "Check for Blowups" option in the construction of the Design Space ([Figure S5](#mmc1){ref-type="supplementary-material"}), we obtain [Figure 2](#fig2){ref-type="fig"}D, which has five additional phenotypes displayed (**7718.1**, **7754.1**, **7758.1**, **9030_10.1**, and **9066_10.1**). Note that the ability to identify pathological phenotypes exhibiting metabolic imbalances is unique to DST3. The dynamical nature of the pathological phenotypes contained in the lower portion of the **Design Space Plot** can be trivially predicted. Decreasing the numerical value of $k_{cat5}$ while keeping all other parameter values constant at the operating point of the system would lead to a steady increase of the toxic intermediate $P_{8}$. A **Trajectories Plot** ([Figure 2](#fig2){ref-type="fig"}E), with $k_{cat5}$ decreased from its nominal value of 1 to 0.01, is used to characterize the dynamics of the Full System when the operating point of the system is located within the region of pathological phenotype **7718.1** ([Figure 2](#fig2){ref-type="fig"}D). In [Figure 2](#fig2){ref-type="fig"}E, the state of the system after numerical integration using the IDA solver (refer to [Table S7](#mmc1){ref-type="supplementary-material"}) is marked by a gray star, whereas the black dot represents the prediction made by DST3 for phenotype **7718.1** using linear algebra (note that the value of 10^12^ is an arbitrarily large value used to signify an approach to infinity). As expected, the numerical analysis of the Full System indicates a continuous accumulation of the toxic intermediate $P_{8}$, whereas the intermediate $CM_{9}$ reaches a steady-state value.

In summary, a comparison of the results obtained by numerical integration of the Full System ([Figures 2](#fig2){ref-type="fig"}C and 2E) demonstrates the ability of DST3 to predict steady-state values when they exist and predict the blow-up nature of a variable when it does not have a steady-state solution.

### Logarithmic Gains Can Guide the Design of Engineering Strategies {#sec2.3.3}

Once a stable and globally robust operating point for a given system has been identified, one might be interested in finding strategies to increase the flux through a specific metabolic pathway or to increase the steady-state concentration of certain intermediate metabolites. Here, we exemplify how an analysis of logarithmic gains can be used to identify such strategies. *Logarithmic gains* are amplification factors relating changes in input signals (independent variables) to the resulting changes in output signals (dependent variables). The term *parameter sensitivity* is used instead of logarithmic gain when the effect of varying a parameter on a dependent variable is analyzed. These parameter (in)sensitivities represent the local robustness of a system, in contrast to the global robustness provided by the volume of the valid region of a phenotype in Design Space. Both logarithmic gains and parameter sensitivities are properties that depend exclusively on the kinetic orders of the system and can be calculated for concentrations or fluxes ([@bib30]). DST3 allows the calculation of logarithmic gains and parameter sensitivities using the tab **Analyze Case** of the **Main Menu** in the user interface ([Figure S9](#mmc1){ref-type="supplementary-material"}A). For simplicity, we will use the term logarithmic gain for both logarithmic gains and parameter sensitivities. [Table 2](#tbl2){ref-type="table"} lists logarithmic gains for the phenotype **7633**, the representative phenotype of the first group of phenotypes with desired properties ([Table 1](#tbl1){ref-type="table"}).Table 2Logarithmic Gains for Phenotype **7633**ModuleParametersChangeDependent Variables$M_{3}$$P_{8}$$CM_{9}$$CL_{10}$$F$Signaling$\alpha_{1}$↓−2000−2$\beta_{1}$↑20002Gene Circuitry$K_{1}$↑20002$\alpha_{3\max}$↑10001$K_{2}$↓−2000−2$\beta_{3}$↓−1000−1$\alpha_{4}$--21113$\beta_{4}$--−2−1−1−1−3$\alpha_{5}$--−2−100−2$\beta_{5}$--21002$\alpha_{6}$--00−100$\beta_{6}$--00100$\alpha_{7}$--000−10$\beta_{7}$--00010Metabolism$k_{cat4}$--21113$K_{M0}$--−2−1−1−1−3$P_{0}$--21113$k_{cat5}$--−2−100−2$K_{M5f}$--21002$k_{cat6}$--00−100$K_{M6f}$--00100$k_{cat7}$--000−10$K_{M7}$--00010[^3]

A number of engineering strategies are contained in [Table 2](#tbl2){ref-type="table"}. For instance, interventions increasing the flux through the metabolic pathway without altering the steady-state concentration of the potentially toxic metabolic intermediate $\text{P}_{8}$ are identified in the third column of [Table 2](#tbl2){ref-type="table"} and are graphically represented in [Figure 3](#fig3){ref-type="fig"}A, where each individual arrow represents a different strategy. Note that all these strategies ultimately lead to an increase in the availability of the mRNA molecule $\text{M}_{3}$ and can be categorized into two groups. The first group contains strategies that *directly* increase the synthesis (by either increasing $\alpha_{3\max}$, decreasing the binding constant $K_{2}$ or increasing $K_{1}$) and reduce the degradation (by decreasing the rate constant $\beta_{3}$) of $\text{M}_{3}$.Figure 3Engineering Strategies for Phenotype **7633**(A) Six different strategies to increase the flux through the metabolic pathway without increasing the steady-state concentration of $\text{P}_{8}$ are shown. Each colored arrow represents an individual strategy. An arrow placed directly over a synthesis or a degradation flux targets its associated rate constant: $\alpha$ for synthesis and $\beta$ for degradation. Arrows located within gray boxes usually target kinetic properties of an enzyme or a process. Blue upward arrows symbolize increase, whereas red downward arrows represent decrease. All of the strategies represented in the figure are biologically feasible. However, modifying kinetic properties of a given enzyme or process requires, in most of the cases, a greater experimental effort than modifying its synthesis rate. The effects of perturbing the maximal synthesis rate of the mRNA molecule $\text{M}_{3}\left( \alpha_{3\max} \right)$ on the flux through the metabolic pathway $\text{F}$ and the steady-state concentration of $\text{P}_{8}$ are shown in (B) and (C), respectively. The operating point of the system is the one depicted in [Figure 2](#fig2){ref-type="fig"}B by the white dot. Vertical dashed lines represent the nominal value of $\alpha_{3\max}$, from which the system is perturbed. The black solid line represents the behavior of phenotype **7633**. The generation of each **Titration Plot** for the Full System involved numerical integration for 100 different values of $\alpha_{3\max}$ within the range \[0.1 100\]. For each point, the system was integrated for 500 time units. To test its stability, the system was integrated for increasing (blue solid line, not shown since covered by orange line) and decreasing $\alpha_{3\max}$ values (orange line). Since the system follows the same path when integrated forward and backward, it exhibits mono-stable behavior, as predicted by DST3 based on the number of eigenvalues with positive real part for phenotype **7633**. Discrepancies in the location of the solid black and orange lines are due to the simplifications made by the Design Space formalism to generate mathematical expressions for phenotype **7633**. However, note that the slope of the black line accurately describes the slope of the orange line.

The second group encompasses *indirect* strategies that point at increasing the steady-state concentration of the activator form of the transcription factor $\text{U}_{2}$ by modifying rate constants ($\text{P}_{8}$ or $\text{M}_{3}$). An analogous analysis can be done to identify strategies increasing the steady-state concentration of metabolic intermediates without increasing the pathway flux. We use the **Full System** tab within the **Main Menu** of the user interface of DST3 ([Figure S11](#mmc1){ref-type="supplementary-material"}) to demonstrate the validity of these predictions by means of two **Titration Plots**. In each case, the maximal synthesis rate $\alpha_{3\max}$ is increased 100-fold and decreased 10-fold from its nominal operating value of 1 and the effect on the pathway flux F ([Figure 3](#fig3){ref-type="fig"}B) and on the steady-state concentration of the toxic metabolic intermediate P~8~ ([Figure 3](#fig3){ref-type="fig"}C) is computed for the Full System. As predicted by a logarithmic gain of $L\left( F,\alpha_{3\max} \right) = 1$ for phenotype **7633**, increasing $\alpha_{3\max}$ leads to an increase in the steady-state flux through the metabolic pathway in the Full System. On the other hand, and as indicated by a logarithmic gain of $L\left( P_{8},\alpha_{3\max} \right) = 0$, increasing or decreasing $\alpha_{3\max}$ has no effect on the steady-state concentration of $\text{P}_{8}$ in the Full System. Thus, *increasing* $\alpha_{3\max}$, which can be experimentally achieved by engineering the promoter region of the polycistronic mRNA or increasing the copy number of the *pca* operon, from its nominal operating value can be used as a strategy to increase the flux through the metabolic pathway without increasing the steady-state concentration of $\text{P}_{8}$.

### DST3 Efficiently Locates Experimentally Observed Induction Patterns of the System {#sec2.3.4}

[@bib38] experimentally characterized the effect exerted by the regulator PcaU from *Acinetobacter* sp. strain ADP1 on the expression of the *pca* genes encoding the protocatechuate pathway studied in this work. Based on expression experiments under different conditions, Trautwein and Gerischer suggested a bifunctional nature of the transcription factor PcaU, concluded that protocatechuate-dependent regulation of the *pca* genes only occurs in the presence of a functional PcaU, and quantitatively characterized the degree of induction of the pathway under different growth conditions. The authors measured a 94-fold induction of the pathway, when the *pca* gene expression was compared between growth on succinate and growth on *p*-hydroxybenzoate---note that *Acinetobacter* sp. strain ADP1 degrades *p*-hydroxybenzoate via protocatechuate, which induces *pca* gene expression by activating the regulator PcaU. On the other hand, succinate or its degradation products do not induce *pca* gene expression. This value represented the highest degree of induction observed by the authors among different growth conditions.

[@bib38] also studied the effect that PcaU had on *pca* gene expression in the absence of the inducer protocatechuate. This analysis involved a wild-type and a mutant strain missing two-thirds of the *pcaU* gene. After growth on succinate, pyruvate, and acetate, the Δ*pcaU* derivative strain expressed between 2- and 3.5-fold higher enzyme levels than the wild-type under the same conditions, thus suggesting that PcaU can act as a repressor in the absence of high concentrations of the inducer protocatechuate.

In section "[Filtering the Phenotypic Repertoire for Phenotypes of Interest](#sec2.3.1){ref-type="sec"}," we filtered the phenotypic repertoire exhibited by the network represented in [Figure 2](#fig2){ref-type="fig"}A to identify 64 phenotypes of interest that were inducible and responded to changes in the concentration of the inducer protocatechuate. Here, we ask the question whether these phenotypes are able to exhibit induction patterns that match the experimental observations made by [@bib38]. Once again, we focus our analysis around phenotype **7633**, which is a representative phenotype for the group 1 in [Table 1](#tbl1){ref-type="table"}. [Figure 4](#fig4){ref-type="fig"}A shows a Design Space plot centered on this phenotype. The x axis corresponds to the logarithm of the concentration of the environmentally supplied substrate protocatechuate $P_{0}$, whereas the y axis corresponds to the logarithm of the total amount of the regulator PcaU present in the system $\left( \text{U}_{\text{T}} \right)$. Parameter values are the same as in [Figure 2](#fig2){ref-type="fig"}B.Figure 4Induction Patterns of the Protocatechuate Pathway Around Phenotype 7633(A) A Design Space plot around phenotype **7633** is shown. An asterisk next to the phenotype number denotes that at least one boundary condition of the phenotype is on the edge. Parameter values are the same as in [Figure 2](#fig2){ref-type="fig"}A.(B) The logarithm of the steady-state concentration of the mRNA molecule $\text{M}_{3}$, a proxy for the expression level of the protocatechuate pathway, is shown as a heatmap. These concentrations were calculated using S-system equations for each one of the phenotypes shown in (A). This plot was created through the **Create Plot** tab of the **Main Menu** of DST3 ([Figure S10](#mmc1){ref-type="supplementary-material"}). As mentioned before, the calculation of steady states within the Design Space formalism only involves matrix operations, rather than numerical integration of the Full System with ODE or DAE solvers. Additionally, note that (B) represents an overview of the potential expression patterns exhibited by the protocatechuate pathway as a function of the external inducer concentration $P_{0}$ and the level of the regulator $\text{U}_{\text{T}}$. Four specific induction patterns (denoted by the white dashed lines in \[B\]) are visualized by means of titration plots.(C--F) (C) and (D) represent titration plots at two different constant levels of $\text{U}_{\text{T}}\left( {\log_{10}\text{U}_{\text{T}} = + 2.5\ \text{and}\  - 2.5,\ \text{respectively}} \right)$. On the other hand, (E) and (F) represent titration plots at two different constant levels of the environmentally supplied inducer protocatechuate $\left( {\log_{10}\left( \text{P}_{0} \right) = - 2.0\ \text{and}\  + 2.0,\ \text{respectively}} \right)$. All titration plots were generated using the parameter values of [Figure 2](#fig2){ref-type="fig"}B and show the fold change between the lowest and highest level of the concentration of the mRNA molecule $\text{M}_{3}$. Black solid lines in each titration plot represent the behavior of specific phenotypes of the system. The generation of each titration plot for the Full System (orange lines) involved numerical integration for 100 different values of the variable shown in the x axis $P_{0}$ or $\text{U}_{\text{T}}$, within the range \[0.001 1000\]. For each step within this range, the system was integrated for 5,000 time units.

To obtain a global view of the expression pattern exhibited by the system around phenotype **7633**, we generated a **Steady State Concentration Plot** ([Figure 4](#fig4){ref-type="fig"}B) of the mRNA molecule $\text{M}_{3}$. This plot has the same axes as [Figure 4](#fig4){ref-type="fig"}A but shows the logarithm of the concentration of the mRNA molecule $\text{M}_{3}$ as a heatmap. Solid black lines in [Figure 4](#fig4){ref-type="fig"}B represent boundaries between phenotypes, whose identity can be obtained from [Figure 4](#fig4){ref-type="fig"}A. Detailed induction patterns were extracted from [Figure 4](#fig4){ref-type="fig"}B by a series of two **Titration Plots** at different constant levels of the regulator PcaU ([Figures 4](#fig4){ref-type="fig"}C and 4D) and two **Titration Plots** at constant levels of $P_{0}$ ([Figures 4](#fig4){ref-type="fig"}E and 4F). The parametric trajectories followed by each one of these titration plots are denoted by the white dashed lines in [Figure 4](#fig4){ref-type="fig"}B.

Taken together, these four titration plots correctly capture key experimental observations made by [@bib38]. [Figure 4](#fig4){ref-type="fig"}C along with [Figure 4](#fig4){ref-type="fig"}D clearly demonstrates that the protocatechuate-dependent regulation of the *pca* genes only occurs in the presence of a sufficiently high concentration of the regulator PcaU $\left( \text{U}_{\text{T}} \right)$. If the concentration of PcaU is too low, or if the regulator is not present in a functional form, increasing the concentration of protocatechuate $\left( \text{P}_{\text{0}} \right)$ will not lead to a change from the basal state of the system, as shown in [Figure 4](#fig4){ref-type="fig"}D by a constant steady-state concentration of the mRNA molecule $\text{M}_{3}$. However, if $\text{U}_{\text{T}}$ is increased to a sufficiently high value, a 100-fold *pca* gene induction by $\text{P}_{\text{0}}$ is observed ([Figure 4](#fig4){ref-type="fig"}C). Interestingly, this extent of induction is in agreement with the maximal induction factor experimentally observed by [@bib38].

Evidence for the *repressor* activity of PcaU at a low protocatechuate level is shown in [Figure 4](#fig4){ref-type="fig"}E by an increase in the steady-state concentration of the mRNA molecule $\text{M}_{3}$ as the total amount of PcaU $\left( \text{U}_{\text{T}} \right)$ is decreased. Interestingly, a calculated 10-fold repression is in the same order of magnitude as the experimentally observed 2- to 3.5-fold repression. Note that, at a high concentration of the inducer, decreasing the total amount of PcaU $\left( \text{U}_{\text{T}} \right)$ leads to a decrease in the steady-state concentration of the mRNA molecule $\text{M}_{3}$, thus reinforcing the observation that PcaU acts as a repressor only at low concentrations of the inducer protocatechuate.

The ability of the underlying mathematical model to correctly describe experimentally observed induction patterns is not completely surprising, partly because the potential for these features was incorporated during the construction of the model. Rather, the information extracted from [Figures 4](#fig4){ref-type="fig"}C--4F confirms the suitability of the model for the mathematical analysis performed in section "[Logarithmic Gains Can Guide the Design of Engineering Strategies](#sec2.3.3){ref-type="sec"}." On the other hand, what is indeed surprising is the ability of the Design Space toolbox to quickly identify and locate regions of a *30-dimensional* parameter space exhibiting desired properties without using any *a priori* knowledge of the involved parameters.

Discussion {#sec3}
==========

The Design Space Toolbox v.3.0 offers a variety of advantages over its predecessor version. By distributing the software via a Docker image, the installation process of DST3 is reduced to installing Docker itself. All necessary software dependencies and configurations are already contained within the Docker image, so that users can focus on the actual application of the tools to the analysis of biochemical systems. To improve software usability, DST3 comes with a more stable user interface. By integrating ODE and DAE solvers into the user interface (see [Table S7](#mmc1){ref-type="supplementary-material"} for further details), it is now possible to directly test independently the accuracy of predictions made by the Design Space formalism from within DST3. Additionally, the capabilities of the computational engine of the Design Space Toolbox were extended. DST3 is now able to analyze biochemical systems containing multiple, nested singularities, something that was out of the reach of previous versions of the toolbox. We demonstrated the utility of DST3 by analyzing a case study of an integrated biochemical system consisting of a signaling cascade, a gene circuit, and a metabolic pathway. The system\'s topology encoded a cycle, a conservation relationship, and the potential to exhibit blow-up behavior.

We applied a recently developed phenotype-centric modeling strategy ([@bib23], [@bib40]) to identify a stable and globally robust operating point of the system. This process involved listing the phenotypic repertoire and filtering it for phenotypes of interest. From a total of 3,450 valid phenotypes, 384 were found to be non-pathological, 192 of these physiological phenotypes were responsive to changes in the concentration of environmental substrate protocatechuate (P~0~), and 64 of the responder phenotypes were found to be inducible. The latter fell into three groups based on the steepness of the induction characteristic: $\text{L}\left( {\text{M}_{3},\text{P}_{0}} \right) = 2$ with 32 phenotypes, $\text{L}\left( {\text{M}_{3},\text{P}_{0}} \right) = 4$ with 28, and $\text{L}\left( {\text{M}_{3},\text{P}_{0}} \right) = 6$ with 4. When compared on the bases of three criteria, global robustness, energy efficiency, and toxicity, the first group was best and the third group was worst. An analysis of the volume of the 64 phenotypes with desired properties revealed that their combined volume only accounted for 5.61 × 10^−5^% of the total volume of all non-pathological phenotypes identified by DST3 (see [Table 1](#tbl1){ref-type="table"}). When pathological phenotypes were considered (phenotypes exhibiting a blow-up behavior), this value decreased to 2.93 × 10^−22^%. This suggests that desirable phenotypes will have to be actively selected for by nature, since the vast majority of parameter values chosen at random (increased entropy) would produce few desirable phenotypes.

These figures highlight the power of DST3 and the phenotype-centric modeling strategy it enables. Finding the reported operating point for the representative phenotype **7633** and characterizing its robustness and associated boundaries in a 30-dimensional parameter space by means of parameter sampling would have been computationally expensive and impractical. Indeed, current methods based on the ensemble modeling approach ([@bib37]) for robustness analysis ([@bib19]) involve computationally expensive dense parameter sampling and numerical integration by ODE solvers for stability assessment. These approaches require a long computational time for large model ensembles, and they do not allow for a rigorous identification of stability boundaries. On the other hand, the Design Space formalism decomposes the parameter space into a set of polytopes, biochemical phenotypes, whose boundaries and properties are well defined. DST3 not only identifies these phenotypes but also allows the automatic prediction of nominal parameter sets for their realization. This greatly facilitates deterministic simulations of the Full System ([@bib12], [@bib41], [@bib26]), which require parameter values, as demonstrated in [Figures 2](#fig2){ref-type="fig"}C and 2E, [Figures 3](#fig3){ref-type="fig"}B and 3C, and [Figures 4](#fig4){ref-type="fig"}C--4F. Similarly, stochastic simulations, which also require parameter values for propensity functions ([@bib9]), can benefit from the innovations offered by DST3.

DST3 predictions regarding steady states, stability, and blow-up behavior were accurate, as demonstrated by time course, titration, and trajectory plots generated for the Full System. By finding strategies to increase the flux through the metabolic pathway of the system without increasing the steady-state concentration of an intermediate metabolite, we aimed at showing a glimpse of the potential that the Design Space formalism has to offer to the field of *rational* Metabolic Engineering ([@bib4]). Further potential applications relate to the ability of DST3 to correctly identify and characterize blow-up phenotypes, which are commonly found in metabolic systems. Often, in the process of strain development, intermediate strains are generated, in which a given intermediate metabolite excessively accumulates or is totally consumed, thus generating a metabolic imbalance within the cell. This decreases strain fitness and can ultimately lead to cellular death ([@bib7], [@bib13], [@bib1]). DST3 is able to identify regions in the parameter space leading to metabolic imbalances and to provide clues to rectify these phenotypes. For instance, consider the operating point of the system shown in [Figure 2](#fig2){ref-type="fig"}D, which is located within the blow-up phenotype **7718.1**. Inspection of the Design Space plot around this phenotype indicates that increasing the value of k~cat5~ to values larger than 0.1 would place the operating point of the system within phenotype **7705**, **7633**, **4,177** or **5,473_6**, all of which exhibit a stable, non-pathological steady state. The specific location of the operating point within any of these phenotypes, and the resulting behavior, will depend on the extent of the increase. Alternative, and more practical strategies to rectify the pathological behavior of an operating point located within phenotype **7718.1** include increasing the amount of the PcaGH enzyme by cloning its gene sequence on a controllable plasmid or engineering its ribosomal binding site.

The application of mechanistic models for the identification of metabolic engineering strategies has been rather limited. This has been mainly caused by a lack of knowledge of associated parameter values. As a consequence, constraint-based modeling has been the method of choice applied to rationally guide metabolic engineering strategies ([@bib39]). By enabling a mechanistic, phenotype-centric modeling strategy not dependent on parameter values, the Design Space formalism and associated toolbox offers enormous potential for the field of metabolic engineering.

Elucidating biological design principles is another important area for application of the Design Space formalism that was not explored in this work owing to space limitations. In the Design Space, boundaries delimiting biochemical phenotypes are linear functions of the system\'s parameters in logarithmic coordinates. Thus, design principles can be readily identified in the form of mathematical inequalities involving the parameters of the system. These ideas were applied by [@bib11] to study properties of toxin-antitoxin systems, which have been linked with the medically relevant persister phenotype exhibited by certain bacterial strains. The study revealed factors affecting the frequency of persisters in the population, such as the overall number of toxin-antitoxin modules and the size and position of the bistable region, a property emerging from the system\'s architecture.

There are many examples of systems that appear to perform the same function, and yet they exhibit radically different genomic architectures, the reasons for which are poorly understood. An example is provided by the protocatechuate degradation pathway studied in this work. It is one of the two branches of the β-ketoadipate pathway, a chromosomally encoded convergent pathway for aromatic compound degradation that is widely distributed in soil bacteria and fungi. Enzyme studies suggest that the pathway is highly conserved in diverse bacteria; however, its regulation and gene organization differ greatly ([@bib14]). For instance, the pathway genes from *Pseudomonas aeruginosa* and *P*. *syringae* are arranged in three and four different clusters, respectively. By contrast, all genes are arranged in a single cluster in *Acinetobacter* sp. ADP1 (studied in this work) and in *P*. *fluorescens* ([@bib17]). It has been suggested that evolutionary processes have shaped moldable aspects of the β-ketoadipate pathway to optimally serve diverse lifestyles of bacteria ([@bib14]). DST3 could be used to compare and contrast inherent aspects of each system, such as its dynamic properties, induction characteristics, and trade-offs regarding energy and toxicity, thus potentially allowing the elucidation of underlying design principles used by nature to create the alternative genomic architectures observed in organisms with different environments and lifestyles.

Limitations of the Study {#sec3.1}
------------------------

Even moderate-sized systems are capable of exhibiting a large number of biochemical phenotypes. The ability to filter the repertoire for specific phenotypes is limited by currently available filtering criteria: hysteretic switches, limit cycle oscillations, global robustness, and logical patterns of system-wide increasing and decreasing responses to a given input stimulus. Although we are developing additional criteria, users may need to develop criteria to characterize phenotypes specifically of interest to them. Although the rigorous definition of boundaries between phenotypes is of primary focus in the novel phenotype-centric modeling strategy, three limitations have their origin in the mathematical transformations used to decompose the Full System into a finite set of dominant biochemical phenotypes (represented by S-Systems) and to mathematically analyze them in the logarithmic space. (1) Numerical accuracy, which becomes undefined at boundaries between phenotypes in parameter space where there is no clear pattern of dominance. We denote the extreme case when the operating point of the system is directly located on a phenotypic boundary by a phenotype number with an asterisk. This limitation can be easily overcome by placing the operating point of the system far away from a phenotypic boundary. The Design Space Toolbox provides necessary functionalities to modify the operating point of the system accordingly (see the tutorial contained in the Docker image under /Tutorials/Tutorial_DST3). (2) The logarithmic transformation employed to linearize S-System equations causes trivial solutions to be ignored. In such a solution, at least one of the dependent variables has a steady-state value of zero. We are currently implementing computational routines that address this limitation. (3) The description of some processes, such as the membrane potential, require mathematical functions (e.g., exponential functions) that cannot be transformed trivially into the GMA form, which in the Design Space formalism is used to represent the Full System. An approximation by rational functions is necessary, and in most cases generating the right approximation requires some expertise. We will be addressing this topic in a future study.

Resource Availability {#sec3.2}
---------------------

### Lead Contact {#sec3.2.1}

Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Michael A. Savageau (<masavageau@ucdavis.edu>).

### Materials Availability {#sec3.2.2}

This study did not generate new unique reagents.

### Data and Code Availability {#sec3.2.3}

The Docker images used by DST3 are freely available at <https://hub.docker.com/r/savageau/dst3>.

Methods {#sec6}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods, Figures S1--S11, and Tables S1--S7
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[^1]: Lead Contact

[^2]: This table was generated for the system described by [Equation S46--S62](#mmc1){ref-type="supplementary-material"} of the [Supplemental Information](#appsec1){ref-type="fn"} using the tab **Phenotypic Repertoire** of the **Main Menu** of the user interface of DST3 ([Figure S6](#mmc1){ref-type="supplementary-material"}B) and filtered for desirable phenotypes as described in the main text.

[^3]: This table was generated using the tab **Analyze Case** of the **Main Menu** in the DST3 user interface. Shown are logarithmic gains for the steady-state concentration of the mRNA molecule $\text{M}_{3}$; the three pathway intermediates $\text{P}_{8},\text{CM}_{9},\ \text{and}\ \text{CL}_{10}$; and the flux through the metabolic pathway $\text{F}$. Parameters with no effect on any of the variables are not shown. A logarithmic gain of 0 indicates no effect. Strategies for changing parameters that increase the pathway flux $\left( \text{F} \right)$ while keeping the intracellular protocatechuate concentration $\left( \text{P}_{8} \right)$ unaltered are identified by an arrow in the third column. A minus sign indicates the lack of an applicable strategy. Refer to [Tables S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"} for the biological context of the symbols used in this table.
